Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Insulet Corp (PODD US)
Watchlist
82
Analysis
Health Care
•
United States
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Eoflow
•
08 Aug 2023 23:54
EOFLOW/Medtronic Tender: Insulet’s US Complaint Materially Increases Deal Break Risks
The most likely scenarios are that Medtronic and Insulet sign a licensing agreement (resulting in a possible price cut) or Medtronic walks. Both...
Arun George
Follow
889 Views
Share
bullish
•
Eoflow
•
27 Jul 2023 15:21
EOFLOW/Medtronic Tender: Assessing the Wide Spread
Our assessment of the key deal risks suggests a low probability of a deal break. At the last close, the gross spread is an attractive 8.5%.
Arun George
Follow
403 Views
Share
bullish
•
Eoflow
•
25 Jul 2023 22:00
An Update on Medtronic's Tender Offer of Eoflow
In this insight, we provide an update of Medtronic's tender offer of Eoflow. We continue to believe there is 95%+ probability of this M&A getting...
Douglas Kim
Follow
423 Views
Share
bearish
•
Tandem Diabetes Care
•
09 Jun 2023 17:48
Tandem Diabetes Care (TNDM US): Missed Earnings + Severe Competition = A Bitter Pill to Swallow
Tandem is consistently missing earnings expectations since 4Q21. The company’s nearest competitor has recently launched a new device in US, which...
Tina Banerjee
Follow
406 Views
Share
bullish
•
Eoflow
•
06 Jun 2023 01:02
EOFLOW/Medtronic Tender: Risk/Reward Profile
The shares are trading wide due to key risks - regulatory approvals and the minimum acceptance condition. Low competition issues facilitate...
Arun George
Follow
490 Views
Share
First
Previous
9
10
11
12
13
14
15
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x